A case report revealing acute onset psychosis and cognitive impairment as primary manifestation in relapsing‐remitting multiple sclerosis

Autor: Anirban Nandy, Michael Nielsen, Claudia Hilt, Poul Henning Mogensen, Yousef Yavarian

Publikováno v: Clinical Case Reports, Vol 8, Iss 5, Pp 833-836 (2020)

Abstract Acute psychosis and cognitive impairment is a significant problem in RRMS. As it concerns in relatively young age group, our case report underscores the importance of early recognition which could impose diagnostic challenge in multiple scle

Externí odkaz: https://doaj.org/article/d83b6f0f29ac4315b7e3267ae5b5873a

Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in the Danish Multiple Sclerosis Registry

Autor: Zsolt Illes, Stephan Bramow, Volkert Siersma, Tobias Sejbaek, Homayoun Roshanisefat, Mathias Buron, Arkadiusz Weglewski, Viktoria Papp, Melinda Magyari, Zsolt Mezei, Svend Sparre Geertsen, Finn Sellebjerg, Janneke van Wingerden, Peter Vestergaard Rasmussen, Matthias Kant, Claudia Hilt

Publikováno v: Papp, V, Buron, M D, Siersma, V, Rasmussen, P V, Illes, Z, Kant, M, Hilt, C, Mezei, Z, Roshanisefat, H, Sejbæk, T, Weglewski, A, Van Wingerden, J, Geertsen, S S, Bramow, S, Sellebjerg, F & Magyari, M 2021, ' Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in the Danish Multiple Sclerosis Registry ', PLOS ONE, vol. 16, no. 5, e0250820 . https://doi.org/10.1371/journal.pone.0250820
PLoS ONE, Vol 16, Iss 5, p e0250820 (2021)
Papp, V, Buron, M D, Siersma, V, Rasmussen, P V, Illes, Z, Kant, M, Hilt, C, Mezei, Z, Roshanisefat, H, Sejbaek, T, Weglewski, A, van Wingerden, J, Geertsen, S S, Bramow, S, Sellebjerg, F & Magyari, M 2021, ' Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry ', PLoS ONE, vol. 16, no. 5, 0250820 . https://doi.org/10.1371/journal.pone.0250820
PLoS ONE
Papp, V, Buron, M D, Siersma, V, Rasmussen, P V, Illes, Z, Kant, M, Hilt, C, Mezei, Z, Roshanisefat, H, Sejbæk, T, Weglewski, A, van Wingerden, J, Geertsen, S S, Bramow, S, Sellebjerg, F & Magyari, M 2021, ' Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry ', PLOS ONE, vol. 16, no. 5, e0250820 . https://doi.org/10.1371/journal.pone.0250820

Objective Teriflunomide is a once-daily, oral disease-modifying therapy (DMT) for relapsing forms of multiple sclerosis (MS). We studied clinical outcomes in a real-world setting involving a population-based large cohort of unselected patients enroll

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a475a534c4fb6343b177993f437df9c
https://vbn.aau.dk/da/publications/14313629-8b97-4183-84c4-d23d820c03f8

Effectiveness of Robotics in Stroke Rehabilitation to Accelerate Upper Extremity Function: Systematic Review

Autor: Cora Carrillo, Devyn Tilley, Kaitlyn Horn, Michelle Gonzalez, Cassidy Coffman, Claudia Hilton, Karthik Mani

Publikováno v: Occupational Therapy International, Vol 2023 (2023)

Objective. To examine the effectiveness of robot-assisted therapy (RAT) combined with conventional therapy (CT) compared to CT alone in accelerating upper extremity (UE) recovery poststroke. Data Sources. We searched five databases: Ovid, MEDLINE, CI

Externí odkaz: https://doaj.org/article/794e5f933e204bd59d2a635b54582f60